Copyright
©The Author(s) 2017.
World J Gastroenterol. Nov 28, 2017; 23(44): 7899-7905
Published online Nov 28, 2017. doi: 10.3748/wjg.v23.i44.7899
Published online Nov 28, 2017. doi: 10.3748/wjg.v23.i44.7899
Table 1 Baseline characteristics of the patients
| Characteristics | Value |
| Total participants (n) | 1375 |
| mean age (yr) mean ± SD (range) | 48 ± 13 (18-65) |
| Gender | |
| Male | 696 (50.62%) |
| Female | 679 (49.38%) |
| Treatment history | |
| Treatment naive | 490 (35.64%) |
| Treatment experienced | 885 (64.36%) |
| Laboratory investigations | |
| Hemoglobin(Hb) (g/dL), mean ± SD (range) | 12.50 ± 3.50 (7.5-18.3) |
| Platelets (103/μL), mean ± SD (range) | 160 ± 76 (50-450) |
| Creatinine (mg/dL) | 0.65 ± 0.22 (0.38-1.50) |
| Mean viral load (106 IU/mL) mean ± SD (range) | 3.54 ±2.56 (0.01-33.98) |
| HCV genotype 3 | 1375 (100%) |
- Citation: Iqbal S, Yousuf MH, Yousaf MI. Dramatic response of hepatitis C patients chronically infected with hepatitis C virus genotype 3 to sofosbuvir-based therapies in Punjab, Pakistan: A prospective study. World J Gastroenterol 2017; 23(44): 7899-7905
- URL: https://www.wjgnet.com/1007-9327/full/v23/i44/7899.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i44.7899